Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $18.6 million.

  • MDxHealth's Share-based Compensation rose 1327.01% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 1327.01%. This contributed to the annual value of $17.1 million for FY2024, which is 4106.6% up from last year.
  • As of Q3 2025, MDxHealth's Share-based Compensation stood at $18.6 million, which was up 1327.01% from $18.2 billion recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Share-based Compensation peaked at $18.2 billion during Q2 2025, and registered a low of $132000.0 during Q1 2022.
  • Its 5-year average for Share-based Compensation is $1.1 billion, with a median of $11.8 million in 2023.
  • Per our database at Business Quant, MDxHealth's Share-based Compensation plummeted by 9451.36% in 2024 and then soared by 11296157.96% in 2025.
  • Over the past 5 years, MDxHealth's Share-based Compensation (Quarter) stood at $555000.0 in 2021, then skyrocketed by 1967.39% to $11.5 million in 2022, then increased by 5.8% to $12.1 million in 2023, then crashed by 94.51% to $666000.0 in 2024, then surged by 2699.1% to $18.6 million in 2025.
  • Its Share-based Compensation stands at $18.6 million for Q3 2025, versus $18.2 billion for Q2 2025 and $17.5 million for Q1 2025.